Speaking Of Medtech, Ep. 7: Real-World Evidence And Data

In this episode of Speaking Of Medtech we’re talking real-world evidence and real-world data – what it is, who’s using it, and why the medtech industry and the US FDA are so keen to collect it. Medtech Insight articles addressing topics discussed in this episode: AdvaMed Asks US FDA To Add Causality, RWE To Safety-Reporting Draft Guidance (https://medtech.pharmaintelligence.informa.com/MT144840/AdvaMed-Asks-US-FDA-To-Add-Causality-RWE-To-SafetyReporting-Draft-Guidance) Real-World Evidence Deemed Essential For Breakthrough Designations (https://medtech.pharmaintelligence.informa.com/MT144525/Real-World-Evidence-Deemed-Essential-For-Breakthrough-Designations) FDA Doc Bemoans ‘Dearth’ Of Pediatric Devices, Says Real-World Data Could ‘Make A Difference’ (https://medtech.pharmaintelligence.informa.com/MT144492/FDA-Doc-Bemoans-Dearth-Of-Pediatric-Devices-Says-RealWorld-Data-Could-Make-A-Difference) Woodcock: Use Of Real-World Evidence Still Brings ‘A Lot Of Problems’ (https://medtech.pharmaintelligence.informa.com/MT144008/Woodcock-Use-Of-Real-World-Evidence-Still-Brings-A-Lot-Of-Problems)